MAI Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Hold
0
738
2026
Q1
Hold
0
642
2025
Q4
Hold
0
580
2025
Q3
Hold
0
635
2025
Q2
Hold
0
369
2025
Q1
Hold
0
330
2024
Q4
Sell
-4,400
Closed -$3.64M 340
2024
Q3
$3.9M Hold
4,400
0.04% 289
2024
Q2
$3.98M Sell
4,400
-400
-8% -$320K 0.04% 291
2024
Q1
$3.73M Buy
4,800
+2,700
+129% +$1.92M 0.04% 292
2023
Q4
$1.22M Hold
2,100
0.02% 420
2023
Q3
$1.13M Hold
2,100
0.02% 407
2023
Q2
$985K Hold
2,100
0.01% 438
2023
Q1
$721K Hold
2,100
0.01% 517
2022
Q4
$768K Sell
2,100
-100
-5% -$35.5K 0.01% 481
2022
Q3
$711K Hold
2,200
0.01% 455
2022
Q2
$713K Buy
+2,200
New +$660K 0.01% 457

Other funds holding LLY

MAI Capital Management's LLY Position: Q2 2026 in Review

MAI Capital Management increased its Eli Lilly (LLY) stake by 33% in Q2 2026, buying an estimated $31.9M and bringing the position to 127,320 shares worth $153M. The position accounts for 0.57% of the portfolio, ranked #36.

MAI Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MAI Capital Management held 127,320 shares of Eli Lilly worth $153M as of Q2 2026.
  • MAI Capital Management bought 31,231 Eli Lilly shares in Q2 2026, an estimated $31.9M.
  • Eli Lilly made up 0.57% of MAI Capital Management's portfolio in Q2 2026, its #36 holding.
  • MAI Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.